[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340812-105":59,"doc-detail-340812-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","probiotic-mixture-attenuates-colorectal-tumorigenesis-in-murine-aomdss-model-by-suppressing-stat3-inducing-apoptotic-p53-and-modulating-gut-microbiota","Probiotic Mixture Attenuates Colorectal Tumorigenesis in Murine AOM/DSS Model by Suppressing STAT3, Inducing Apoptotic p53 and Modulating Gut Microbiota","","Colorectal cancer remains a leading cause of morbidity and mortality worldwide, while standard chemotherapy with 5-fluorouracil shows limited response and chemoresistance. This study evaluates Prohep, a novel probiotic mixture, for its ability to reduce azoxymethane/dextran sodium sulfate-induced colorectal tumorigenesis and improve 5-FU efficacy. Prohep demonstrates stronger anti-tumorigenesis effects than 5-FU alone or combined, lowering tumor burden, inflammation, and fibrosis, while suppressing TNF-α and p-STAT3 and increasing apoptotic p53. Multi-omics links these benefits to remodeling of gut microbiota and CRC-related metabolic pathways.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/probiotic-mixture-attenuates-colorectal-tumorigenesis-in-murine-aomdss-model-by-suppressing-stat3-inducing-apoptotic-p53-and-modulating-gut-microbiota/340812/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/probiotic-mixture-attenuates-colorectal-tumorigenesis-in-murine-aomdss-model-by-suppressing-stat3-inducing-apoptotic-p53-and-modulating-gut-microbiota/340812.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does this study address in colorectal cancer treatment?","Question",{"text":112,"@type":113},"The study addresses poor response rates and chemoresistance associated with 5-fluorouracil, motivating the need for more effective and affordable therapies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does Prohep affect tumorigenesis in the AOM/DSS murine model?",{"text":117,"@type":113},"Prohep reduces total tumor count and size, caecum weight, colonic crypt depth, inflammation, and collagen fibrosis, showing stronger anti-tumorigenesis effects than 5-FU alone or combined.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular and microbiota changes are reported with Prohep treatment?",{"text":121,"@type":113},"Prohep downregulates pro-inflammatory TNF-α and proliferative p-STAT3 while upregulating apoptotic p53. Metagenomic and KEGG/Metacyc analyses indicate Prohep reshapes gut microbiota composition and suppresses CRC-related pathways while enhancing metabolite pathways linked to anti-CRC effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340812,1790154487,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Probiotics and Antimicrobial Proteins (2025) 17:2227–2243  \n[https://doi.org/10.1007/s12602-024-10405-1](https://doi.org/10.1007/s12602-024-10405-1)  \nProbiotic Mixture Attenuates Colorectal Tumorigenesis in Murine AOM/DSS Model by Suppressing STAT3, Inducing Apoptotic p53 and Modulating Gut Microbiota  \nHoi Kit Matthew Leung1 · Emily Kwun Kwan Lo1 · Congjia Chen1 · Fangfei Zhang1 · Felicianna1 · Marsena Jasiel Ismaiah1 · Hani El‑Nezami1,2  \nAccepted: 11 November 2024 / Published online: 6 December 2024 © The Author(s) 2024  \nAbstract  \nColorectal cancer (CRC) is one of the most common cancers worldwide. The standard CRC chemo drug, 5-Fluorouracil (5-FU), has a poor response rate and chemoresistance, prompting the need for a more effective and affordable treatment. In this study, we aimed to evaluate whether Prohep, a novel probiotic mixture, would alleviate azoxymethane/dextran sodium sulfate (AOM/DSS)-induced colorectal tumorigenesis and enhance 5-FU efficacy and its mechanism. Our results suggested that Prohep showed stronger anti-tumorigenesis effects than 5-FU alone or when combined in the AOM/DSS model. Prohep significantly reduced the total tumor count, total tumor size, caecum weight, colonic crypt depth, colonic inflammation, and collagen fibrosis. Prohep downregulated pro-inflammatory TNF-α and proliferative p-STAT3 and upregulated apoptotic p53 . Metagenomics analysis indicated that Prohep-enriched Helicobacter ganmani, Desulfovibrio porci, Helicobacter hepaticus, and Candidatus Borkfalkia ceftriaxoniphila were inversely correlated to the total tumor count. In addition, Prohep-enriched Prevotella sp. PTAC and Desulfovibrio porci were negatively correlated to AOM/DSS enriched bacteria, while forming a co-existing community with other beneficial bacteria. From KEGG analysis, Prohep downregulated CRC-related pathways and enhanced pathways related to metabolites suppressing CRC like menaquinone, tetrapyrrole, aminolevulinic acid, and tetrahydrofolate. From Metacyc analysis, Prohep downregulated CRC-related peptidoglycan, LPS, and uric acid biosynthesis, and conversion. Prohep elevated the biosynthesis of the beneficial L-lysine, lipoic acid, pyrimidine, and palmitate. Prohep also elevated metabolic pathways related to energy utilization of lactic acid-producing bacteria (LAB) and acetate producers. Similarly, fecal acetate concentration was upregulated by Prohep. To sum up, Prohep demonstrated exceptional anti-tumorigenesis effects in the AOM/DSS model, which revealed its potential to develop into a novel CRC therapeutic in the future.  \nKeywords Prohep · Probiotic mixture · Colorectal cancer · Gut microbiota · Acetate  \nHoi Kit Matthew Leung and Emily Kwun Kwan Lo equally contributed to the manuscript.  \n* Hani El-Nezami elnezami@hku.hk  \n1 School of Biological Sciences, University of Hong Kong, Pokfulam, Hong Kong 999077, China  \n2 Institute of Public Health and Clinical Nutrition, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland  \nIntroduction  \nColorectal cancer (CRC) is the third most diagnosed cancer, as well as the second leading cause of cancer death worldwide [1, 2] . Over half of the cases are accounted for risk factors including smoking, an unhealthy diet, high alcohol consumption, physical inactivity, and excess body weight [3] . The diagnosis of CRC is often at later stages, and its 5-year survival rate at the advanced stage is only 15%, indicating the importance of early diagnosis and effective treatment [4] . Surgical treatments, including endoscopic mucosal resection and endoscopic submucosal dissection in the early stages and lymph node dissection in the advanced stages along with polyps removal, are the standard first-line treatment for  \nCRC [5]. Apart from surgical procedures, chemotherapeutic intervention is crucial to prevent and cure metastatic CRC and improve patients’ survival rates [6] . Nonetheless, the response rate of the standard chemo drug backbone 5-fluorouracil (5","cbCaik0omGjnNEQR","https://ap.wps.com/l/cbCaik0omGjnNEQR","pdf",8552933,17,"English","# Abstract\n# Introduction","[{\"question\":\"What problem does this study address in colorectal cancer treatment?\",\"answer\":\"The study addresses poor response rates and chemoresistance associated with 5-fluorouracil, motivating the need for more effective and affordable therapies.\"},{\"question\":\"How does Prohep affect tumorigenesis in the AOM/DSS murine model?\",\"answer\":\"Prohep reduces total tumor count and size, caecum weight, colonic crypt depth, inflammation, and collagen fibrosis, showing stronger anti-tumorigenesis effects than 5-FU alone or combined.\"},{\"question\":\"What molecular and microbiota changes are reported with Prohep treatment?\",\"answer\":\"Prohep downregulates pro-inflammatory TNF-α and proliferative p-STAT3 while upregulating apoptotic p53. Metagenomic and KEGG/Metacyc analyses indicate Prohep reshapes gut microbiota composition and suppresses CRC-related pathways while enhancing metabolite pathways linked to anti-CRC effects.\"}]","Probiotic Mixture Attenuates Colorectal Tumorigenesis in Murine AOM/DSS Model by Suppressing STAT3, Inducing Apoptotic p53 and Modulating Gut Microbiota | PDF",1790038969,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff6b9b10c0eed4016a80f0f31d2c3b1f.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5c79acb9e24be457fa54c53c7930fea.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/494f292f5db79ee577d594270dda8e27.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1cc360aa18bdd4f2a3c33f97f0e116f4.webp",980,1301]